ImaBiotech Corporation

https://www.imabiotech.com

ImaBiotech is a Contract Research Organization (CRO) with facilities in Boston (MA, USA) and Lille (Eurasanté Parc, France). The company offers innovative services and software to the pharmaceutical research sector, providing highly in vivo informative drug efficacy and toxicity evaluations during preclinical and clinical stage developments at cellular level, making better and safer drugs. Services are based on histology combined to label free molecular imaging (Quantitative Mass Spectrometry Imaging, QMSI) a technology developed and constantly improved by ImaBiotech. QMSI is a game changer for the pharmaceutical industry in all therapeutic areas. While other techniques provide global information, this molecular technique provides a deeper understanding of a drugs localization and its pharmacological effects at cellular level. This improves the interpretation of drug efficacy and toxicity, resulting in better drugs and decreasing time-to-market. *

Contact: contact@imabiotech.com

Profile: Located in Europe (France) and North America (Cambridge, MA), ImaBiotech develops and offers new imaging technologies, applications and software (Quantinetix™, Multimaging™). In order to accelerates drug development with innovative & proprietary imaging technologies, ImaBiotech offers Mass Spectrometry Imaging Services to provide a cost-effective solution to preclinical and clinical studies. This molecular technique is used for qualitative & quantitative efficacy and toxicity evaluations of drug candidates from the whole body to cell levels.

Industry: Biotechnology

Products/Services: Biomarker discovery, target engagement, analysis of quantitative distributions of your lead compounds, toxicity studies with QMSI to identify the relation between drug, metabolites and toxicity.

Established: 2009

Employees: 20

Partners: Bruker, Prof. Ron Heern, Dr. Walter Korfmacher, Dr. Markus Stoeckli

The organisation submitted the information to [MSC] on 21 March 2016.

	Start	2016-03-21 existent
	Group	ImaBiotech (Group)
	Industry	mass spectrometry software (MS software)
	Industry 2	Quantinetix™ software for quantitative MALDI imaging

	Region	Cambridge, MA
	Country	United States (USA)
	Street	185 Alewife Brook Parkway
	City	02138 Cambridge, MA
	Tel	+1-857-777-6764
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: ImaBiotech SAS. (1/17/19). "Press Release: OCR and ImaBiotech Initiate a Strategic Partnership to Provide in situ Drug Efficacy and Target Exposure Services in Pets with Naturally Occuring Tumors". Lille.

		Record changed: 2019-07-13